Amelia Pinto

Assistant Professor

University of Kentucky

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Amelia Pinto is an Assistant Professor at the University of Kentucky, USA. Her research focuses on vaccine development and immune responses, particularly in relation to influenza, Powassan virus, and SARS-CoV-2. Recent articles include studies on mRNA vaccines, immune protection mechanisms, and the interplay between viruses and host immune systems.

Articles (9)

Year:

2025

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (5)

Carolina Lopez

Professor

Washington University in St. Louis

UNITED STATES

View details

Todd Green

University of Alabama, Tuscaloosa

UNITED STATES

View details

R. Glenn King

The University of Alabama

UNITED STATES

View details

James Brien

Assistant Professor

University of Kentucky

UNITED STATES

View details

Kevin Harrod

Endowed Chair and Professor

The University of Alabama

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Amelia Pinto

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

DDO-adjuvanted influenza A virus nucleoprotein mRNA vaccine induces robust humoral and cellular type 1 immune responses and protects mice from challenge

Titration and neutralizing antibody quantification by focus forming assay for Powassan virus

Balanced T and B cell responses are required for immune protection against Powassan virus in virus-like particle vaccination

Roles of antiviral sensing and type I interferon signaling in the restriction of SARS-CoV-2 replication

Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge

Prior Heterologous Flavivirus Exposure Results in Reduced Pathogenesis in a Mouse Model of Zika Virus Infection

A Dengue Virus Serotype 1 mRNA-LNP Vaccine Elicits Protective Immune Responses

Oxidized Lipoproteins Promote Resistance to Cancer Immunotherapy Independent of Patient Obesity

SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells

Collaborators (5)

Carolina Lopez

Todd Green

R. Glenn King

James Brien

Kevin Harrod

Make your next move.